Dr. Nadia K. Waheed, M.D.
Ophthalmology (Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician)
- Medicare participating
At a glance
- Years since graduation
- 28
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 175
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician primary
MA license 222530 -
Ophthalmology Physician
MA license 222530 · OH license 35.088178
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Tufts Medical Center Boston, MA
Medical groups
- Pratt Ophthalmology Associates Inc (53 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 175
- Services billed
- 426
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Established patient complete exam of visual system | 191 | 163 |
| Imaging of retina | 144 | 82 |
| Injection of drug into eye | 111 | 39 |
| Established patient problem focused exam of visual system | 12 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 1 companies reported 6 payments worth $56,000 in total to this clinician.
| Topcon Healthcare, Inc. | $56,000 |
|---|
| Consulting Fee | $45,000 |
|---|---|
| Honoraria | $6,000 |
| Travel and Lodging | $5,000 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Topcon Healthcare, Inc. Jan 27, 2025 | Consulting FeeCompany’s descriptionCONSULTING | $15,000 |
| Topcon Healthcare, Inc. Dec 8, 2025 | Consulting FeeCompany’s descriptionCONSULTING | $15,000 |
| Topcon Healthcare, Inc. Dec 8, 2025 | Consulting FeeCompany’s descriptionCONSULTING | $15,000 |
| Topcon Healthcare, Inc. Dec 22, 2025 | Travel and Lodging travel to FLORENCE, Italy Company’s descriptionFLIGHT | $5,000 |
| Topcon Healthcare, Inc. Oct 27, 2025 | HonorariaCompany’s descriptionHONORARIUM | $4,500 |
| Topcon Healthcare, Inc. May 12, 2025 | HonorariaCompany’s descriptionHONORARIUM | $1,500 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $50,773 in research payments for these studies, mostly to the institutions running them.
- Novel Functional Imaging for Ocular blood flow with Optical Coherence Tomography Angiography
Topcon Corporation
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.